159 related articles for article (PubMed ID: 9515750)
1. Is the sensitivity to gastric acid inhibition Helicobacter pylori status-dependent?
Smout AJ
Scand J Gastroenterol Suppl; 1998; 225():32-5. PubMed ID: 9515750
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
3. The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy.
Peters FT; Kuipers EJ; Ganesh S; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
Aliment Pharmacol Ther; 1999 Jul; 13(7):921-6. PubMed ID: 10383527
[TBL] [Abstract][Full Text] [Related]
4. Review article: the clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease.
Martínek J; Kuzela L; Spicák J; Vavrecka A
Aliment Pharmacol Ther; 2000 Aug; 14(8):979-90. PubMed ID: 10930891
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.
Gillen D; Wirz AA; Neithercut WD; Ardill JE; McColl KE
Gut; 1999 Apr; 44(4):468-75. PubMed ID: 10075952
[TBL] [Abstract][Full Text] [Related]
6. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
[TBL] [Abstract][Full Text] [Related]
7. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
[TBL] [Abstract][Full Text] [Related]
8. Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection.
Martínek J; Blum AL; Stolte M; Hartmann M; Verdú EF; Lühmann R; Dorta G; Wiesel P
Aliment Pharmacol Ther; 1999 Jan; 13(1):27-34. PubMed ID: 9892876
[TBL] [Abstract][Full Text] [Related]
9. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.
Sanduleanu S; Jonkers D; De Bruine A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Mar; 15(3):379-88. PubMed ID: 11207513
[TBL] [Abstract][Full Text] [Related]
10. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
11. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.
Labenz J; Tillenburg B; Peitz U; Verdú E; Stolte M; Börsch G; Blum AL
Gut; 1997 Jul; 41(1):33-6. PubMed ID: 9274468
[TBL] [Abstract][Full Text] [Related]
12. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
13. Review article: is Helicobacter pylori status relevant in the management of GORD?
Vigneri S; Termini R; Savarino V; Pace F
Aliment Pharmacol Ther; 2000 Oct; 14 Suppl 3():31-42. PubMed ID: 11050485
[TBL] [Abstract][Full Text] [Related]
14. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.
Verdú EF; Armstrong D; Idström JP; Labenz J; Stolte M; Dorta G; Börsch G; Blum AL
Gut; 1995 Dec; 37(6):743-8. PubMed ID: 8537042
[TBL] [Abstract][Full Text] [Related]
15. The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection.
Bercík P; Verdú EF; Armstrong D; Idström JP; Cederberg C; Markert M; Crabtree JE; Stolte M; Blum AL
Am J Gastroenterol; 2000 Apr; 95(4):947-55. PubMed ID: 10763943
[TBL] [Abstract][Full Text] [Related]
16. Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients.
Qvigstad G; Arnestad JS; Brenna E; Waldum HL
Scand J Gastroenterol; 1998 Dec; 33(12):1244-8. PubMed ID: 9930386
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
Langtry HD; Wilde MI
Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
[TBL] [Abstract][Full Text] [Related]
18. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
Ciociola AA; Webb DD; Heath A; Walsh JH
Aliment Pharmacol Ther; 1996 Dec; 10(6):905-12. PubMed ID: 8971287
[TBL] [Abstract][Full Text] [Related]
19. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.
Gillen D; Wirz AA; Ardill JE; McColl KE
Gastroenterology; 1999 Feb; 116(2):239-47. PubMed ID: 9922302
[TBL] [Abstract][Full Text] [Related]
20. CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Tanigawara Y; Aoyama N; Kita T; Shirakawa K; Komada F; Kasuga M; Okumura K
Clin Pharmacol Ther; 1999 Nov; 66(5):528-34. PubMed ID: 10579481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
